Report Detail
Global Nuclear Medicine Market Size, Status and Forecast 2019-2025
- RnM3412293 |
- 13 May, 2019 |
- Global |
- 94 Pages |
- QYResearch |
- Other
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In 2018, the global Nuclear Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nuclear Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nuclear Medicine development in United States, Europe and China.
The key players covered in this study
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Market segment by Type, the product can be split into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Market segment by Application, split into
Diagnostic
Therapeutic
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Nuclear Medicine status, future forecast, growth opportunity, key market and key players.
To present the Nuclear Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Nuclear Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Nuclear Medicine Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Tc-99
- 1.4.3 I-123/131
- 1.4.4 In-111
- 1.4.5 Xe-133
- 1.4.6 Th-201
- 1.4.7 Ga-67
- 1.4.8 Other
- 1.5 Market by Application
- 1.5.1 Global Nuclear Medicine Market Share by Application (2014-2025)
- 1.5.2 Diagnostic
- 1.5.3 Therapeutic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Nuclear Medicine Market Size
- 2.2 Nuclear Medicine Growth Trends by Regions
- 2.2.1 Nuclear Medicine Market Size by Regions (2014-2025)
- 2.2.2 Nuclear Medicine Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Nuclear Medicine Market Size by by Players
- 3.1.1 Global Nuclear Medicine Revenue by by Players (2014-2019)
- 3.1.2 Global Nuclear Medicine Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2 Nuclear Medicine Key Players Head office and Area Served
- 3.3 Key Players Nuclear Medicine Product/Solution/Service
- 3.4 Date of Enter into Nuclear Medicine Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Nuclear Medicine Market Size by Type (2014-2019)
- 4.2 Global Nuclear Medicine Market Size by Application (2014-2019)
5 United States
- 5.1 United States Nuclear Medicine Market Size (2014-2019)
- 5.2 Nuclear Medicine Key Players in United States
- 5.3 United States Nuclear Medicine Market Size by Type
- 5.4 United States Nuclear Medicine Market Size by Application
6 Europe
- 6.1 Europe Nuclear Medicine Market Size (2014-2019)
- 6.2 Nuclear Medicine Key Players in Europe
- 6.3 Europe Nuclear Medicine Market Size by Type
- 6.4 Europe Nuclear Medicine Market Size by Application
7 China
- 7.1 China Nuclear Medicine Market Size (2014-2019)
- 7.2 Nuclear Medicine Key Players in China
- 7.3 China Nuclear Medicine Market Size by Type
- 7.4 China Nuclear Medicine Market Size by Application
8 Japan
- 8.1 Japan Nuclear Medicine Market Size (2014-2019)
- 8.2 Nuclear Medicine Key Players in Japan
- 8.3 Japan Nuclear Medicine Market Size by Type
- 8.4 Japan Nuclear Medicine Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Nuclear Medicine Market Size (2014-2019)
- 9.2 Nuclear Medicine Key Players in Southeast Asia
- 9.3 Southeast Asia Nuclear Medicine Market Size by Type
- 9.4 Southeast Asia Nuclear Medicine Market Size by Application
10 India
- 10.1 India Nuclear Medicine Market Size (2014-2019)
- 10.2 Nuclear Medicine Key Players in India
- 10.3 India Nuclear Medicine Market Size by Type
- 10.4 India Nuclear Medicine Market Size by Application
11 Central & South America
- 11.1 Central & South America Nuclear Medicine Market Size (2014-2019)
- 11.2 Nuclear Medicine Key Players in Central & South America
- 11.3 Central & South America Nuclear Medicine Market Size by Type
- 11.4 Central & South America Nuclear Medicine Market Size by Application
12 International Players Profiles
- 12.1 GE Healthcare
- 12.1.1 GE Healthcare Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Nuclear Medicine Introduction
- 12.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2014-2019)
- 12.1.5 GE Healthcare Recent Development
- 12.2 Bracco Imaging
- 12.2.1 Bracco Imaging Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Nuclear Medicine Introduction
- 12.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2014-2019)
- 12.2.5 Bracco Imaging Recent Development
- 12.3 Mallinckrodt
- 12.3.1 Mallinckrodt Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Nuclear Medicine Introduction
- 12.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2014-2019)
- 12.3.5 Mallinckrodt Recent Development
- 12.4 Lantheus Medical Imaging
- 12.4.1 Lantheus Medical Imaging Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Nuclear Medicine Introduction
- 12.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2014-2019)
- 12.4.5 Lantheus Medical Imaging Recent Development
- 12.5 Bayer
- 12.5.1 Bayer Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Nuclear Medicine Introduction
- 12.5.4 Bayer Revenue in Nuclear Medicine Business (2014-2019)
- 12.5.5 Bayer Recent Development
- 12.6 Jubilant Pharma
- 12.6.1 Jubilant Pharma Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Nuclear Medicine Introduction
- 12.6.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2014-2019)
- 12.6.5 Jubilant Pharma Recent Development
- 12.7 Nordion
- 12.7.1 Nordion Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Nuclear Medicine Introduction
- 12.7.4 Nordion Revenue in Nuclear Medicine Business (2014-2019)
- 12.7.5 Nordion Recent Development
- 12.8 Eli Lilly
- 12.8.1 Eli Lilly Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Nuclear Medicine Introduction
- 12.8.4 Eli Lilly Revenue in Nuclear Medicine Business (2014-2019)
- 12.8.5 Eli Lilly Recent Development
- 12.9 SIEMENS
- 12.9.1 SIEMENS Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Nuclear Medicine Introduction
- 12.9.4 SIEMENS Revenue in Nuclear Medicine Business (2014-2019)
- 12.9.5 SIEMENS Recent Development
- 12.10 China Isotope & Radiation
- 12.10.1 China Isotope & Radiation Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Nuclear Medicine Introduction
- 12.10.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2014-2019)
- 12.10.5 China Isotope & Radiation Recent Development
- 12.11 Yantai Dongcheng Biochemicals
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Nuclear Medicine. Industry analysis & Market Report on Nuclear Medicine is a syndicated market report, published as Global Nuclear Medicine Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
